Friday, September 7, 2012

Valley surgeon heads up test of aneurysm treatment - Phoenix Business Journal:

a-ee85aqa.blogspot.com
Rodriguez, the director of peripheral vascular services at the ArizonaHeart Institute, has been namedc the national principal investigator for the Phase II study, whicnh is required by the to enroll 160 The Arizona Heart Institute is one of 14 centeres involved in the study “We are looking to include at least six more centers to completer 20 centers in the U.S.,” Rodriguez The endoluminal graft is manufactured by near Scotland. Called the Anaconda Stent Graft System, it allowse the surgeon to reposition the devices once it has been placesd acrossthe aneurysm.
So far, nearly 4,000 patientz in Europe have received theAnacondas device, but it must get approval from the FDA before it can be used in the U.S. Rodrigue said the minimally invasive procedure onthe study’s first patient went saying the device is very easy to use. “H was up on his feet the next morninvghaving breakfast,” Rodriguez said of the “You can’t do that when you open the chest. This eliminatees the need for openheart surgery.” Abdominal aortic aneurysm, or “ballooning” of the body’s main is a serious condition prone to rupture and lead to sudden Actor John Ritter died of an aorticf rupture in 2003.
Symptoms can occur suddenl with severe, sharp pain in the abdomen. Patients who experiencs these symptoms should seek immediatemedicapl attention, Rodriguez said. Early detection can prevent sudden Patients with a family historh of aortic aneurysm or other connective tissue disorder should notify their physician aboutr their risk ofaortic aneurysm, he said.

No comments:

Post a Comment